Good health and wellness in indian country - component 2 - background: american indians and alaska native (AI/an) people suffer from a high chronic disease burden and multiple chronic disease…

Good health and wellness in indian country - component 2 - background: american indians and alaska native (AI/an) people suffer from a high chronic disease burden and multiple chronic disease disparities. Heart disease, diabetes, and stroke are among the top 10 leading causes of death among AI/an people. AI/an people have significantly higher heart disease and stroke mortality rates than U.S. Whites and the prevalence of diabetes among AI/an people has increased 158% since 1990. The alaska native tribal health consortium (anthc) is a statewide, tribally-designated health services organization that serves the nearly 170,000 AI/an people and all 229 federally-recognized tribes in the indian health service (IHS) alaska area. Purpose: the alaska native tribal health consortium (anthc) alaska native epidemiology center (anec) is applying for the CDC-RFA-DP19-1903, good health and wellness in indian country (ghwic) component 3 funding opportunity to serve as the tribal coordinating center (TCC) to achieve the purpose of reducing rates of mortality and morbidity from commercial tobacco use, diabetes, heart disease and stroke; reduce the prevalence of obesity; and prevention of other chronic disease risk factors and conditions (e.g., oral health, dementia, copd) in american indians and alaska native (AI/an) populations. Anec will establish the TCC to 1) promote achievements, value, and impact of the national ghwic program through the use of a communication plan; 2) collaborate with the centers for disease control and prevention?s (CDC) evaluators in the development and implementation of a ghwic national evaluation plan (NEP); and 3) facilitate the efficient peer-to-peer exchange of chronic disease prevention knowledge?such as best- or promising-practices, lessons learned, and success stories?including nurturing and stewarding a virtual ghwic community of practice. In this role, anec proposes to provide evaluation technical assistance and technological support to all component 1 and component 2 recipients (C1C2RS). Outcomes: by the end of the 5-year project period, anec will achieve the short-term outcomes associated with the component 3 strategy of establishing a TCC for conducting national ghwic program collaborative activities across all three C3 strategies. Short-term outcomes include: 1) increased number of promising practices and success stories identified demonstrating a measurable impact of the program; 2) increased number of C1C2RS using their data and evaluation findings to monitor progress in achieving the nofo outcomes and to inform program improvements; and 3) increased participation among C1C2RS in a collaborative community of practice. By the end of the project period the intermediate-term outcomes achieved will include: 1) increased number of ghwic promising practices and success stories disseminated among AI/an communities; 2) increased number of C1C2RS submitting data to CDC to evaluate the national program in aggregate; and 3) increased number of promising practices, lessons learned, and success stories identified, shared, and implemented over time. Through this funding, anec will also make progress toward the long-term outcomes, beyond the scope of this project period, which are increased adoption and implementation of ghwic promising practices within AI/an communities and increased implementation of quality improvement activities.